...
首页> 外文期刊>Applied Microbiology >Novel Group of Leaderless Multipeptide Bacteriocins from Gram-Positive Bacteria
【24h】

Novel Group of Leaderless Multipeptide Bacteriocins from Gram-Positive Bacteria

机译:革兰氏阳性细菌无领导者多肽细菌素的新组。

获取原文
           

摘要

From raw milk we found 10 Lactococcus garvieae isolates that produce a new broad-spectrum bacteriocin. Though the isolates were obtained from different farms, they turned out to possess identical inhibitory spectra, fermentation profiles of sugars, and repetitive sequence-based PCR (rep-PCR) DNA patterns, indicating that they produce the same bacteriocin. One of the isolates ( L. garvieae KS1546) was chosen for further assessment. Purification and peptide sequencing combined with genome sequencing revealed that the antimicrobial activity was due to a bacteriocin unit composed of three similar peptides of 32 to 34 amino acids. The three peptides are produced without leader sequences, and their genes are located next to each other in an operon-like structure, adjacent to the genes normally involved in bacteriocin transport (ABC transporter) and self-immunity. The bacteriocin, termed garvicin KS (GarKS), showed sequence homology to four multipeptide bacteriocins in databases: the known staphylococcal aureocin A70, consisting of four peptides, and three unannotated putative multipeptide bacteriocins produced by Bacillus cereus . All these multipeptide bacteriocin loci show conserved genetic organization, including being located adjacent to conserved genetic determinants (Cro/cI and integrase) which are normally associated with mobile genetic elements or genome rearrangements. The antimicrobial activity of all multipeptide bacteriocins was confirmed with synthetic peptides, and all were shown to have broad antimicrobial spectra, with GarKS being the most active of them. The inhibitory spectrum of GarKS includes important pathogens belonging to the genera Staphylococcus , Bacillus , Listeria , and Enterococcus .IMPORTANCE Bacterial resistance to antibiotics is a very serious global problem. There are no new antibiotics with novel antimicrobial mechanisms in clinical trials. Bacteriocins use antimicrobial mechanisms different from those of antibiotics and can kill antibiotic-resistant bacteria, but the number of bacteriocins with very broad antimicrobial spectra is very small. In this study, we have found and purified a novel three-peptide bacteriocin, garvicin KS. By homology search, we were able to find one known and three novel sequence-related bacteriocins consisting of 3 or 4 peptides. None of the peptides has modified amino acids in its sequence. Thus, the activity of all bacteriocins was confirmed with chemically synthesized peptides. All of them, especially garvicin KS, have very broad antibacterial spectra, thus representing a great potential in antimicrobial applications in the food industry and medicine.
机译:从生牛奶中,我们发现了10种分离出的加维乳杆菌,它们产生了一种新的广谱细菌素。尽管这些分离株来自不同的农场,但它们却具有相同的抑制谱,糖的发酵图谱以及基于重复序列的PCR(rep-PCR)DNA模式,表明它们产生的细菌素相同。选择一种分离株(L. garvieae KS1546)进行进一步评估。纯化和肽测序与基因组测序相结合表明,抗菌活性是由于细菌素单元由32至34个氨基酸的三个相似肽组成。产生的三种肽没有前导序列,它们的基因以操纵子样结构彼此相邻,与通常参与细菌素转运(ABC转运蛋白)和自身免疫的基因相邻。该细菌素被称为Garvicin KS(GarKS),与数据库中的四种多肽细菌素具有序列同源性:已知的葡萄球菌金黄色素A70(由四种肽组成)和三种蜡状芽孢杆菌产生的未注释的推定多肽细菌素。所有这些多肽细菌素基因座均显示出保守的遗传组织,包括位于通常与移动遗传元件或基因组重排相关的保守遗传决定簇(Cro / cI和整合酶)附近。合成肽证实了所有多肽细菌素的抗菌活性,并且均显示具有宽广的抗菌谱,其中GarKS最为活跃。 GarKS的抑制谱包括葡萄球菌,芽孢杆菌,李斯特菌和肠球菌属的重要病原体。重要提示细菌对抗生素的耐药性是一个非常严重的全球性问题。在临床试验中没有新的抗生素具有新颖的抗菌机制。细菌素使用的抗菌机制与抗生素不同,可以杀死抗药性细菌,但是具有很宽的抗菌谱的细菌素的数量很少。在这项研究中,我们发现并纯化了一种新型的三肽细菌素,Garvicin KS。通过同源性搜索,我们能够找到一种由3个或4个肽组成的已知和三种新颖的与序列相关的细菌素。没有一种肽的序列具有修饰的氨基酸。因此,用化学合成的肽证实了所有细菌素的活性。所有这些,特别是Garvicin KS,都具有非常宽的抗菌谱,因此在食品工业和医药领域的抗菌应用中具有很大的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号